N. Botwood

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Alex Y. Chang, Purvish M. Parikh, Sumitra Thongprasert et al. · Journal of Thoracic Oncology · 2006 · 168 citations · Full text

Medicine, Oncology, Pharmacology +7

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Alex Y. Chang, Purvish M. Parikh, Sumitra Thongprasert et al. · Journal of Thoracic Oncology · 2006 · 129 citations

Medicine, Oncology, Pharmacology +7

Combination Therapy With Gefitinib and Rofecoxib in Patients With Platinum-Pretreated Relapsed Non–Small-Cell Lung Cancer

Kenneth J. O’Byrne, Sarah Danson, David J. Dunlop et al. · Journal of Clinical Oncology · 2007 · 49 citations

Medicine, Oncology, Pharmacology +17

Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer

M Lees, M Aristides, N Maniadakis et al. · PharmacoEconomics · 2002 · 45 citations

Medicine, Oncology, Pharmacoeconomics +16

Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III

Jane Robertson, N. Botwood, Mace L. Rothenberg et al. · Clinical Colorectal Cancer · 2009 · 42 citations

Medicine, Oncology, Pharmacotherapy +11